224 related articles for article (PubMed ID: 35443818)
1. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis.
Sun L; Han Y; Wang H; Liu H; Liu S; Yang H; Ren X; Fang Y
J Int Med Res; 2022 Apr; 50(4):3000605221089503. PubMed ID: 35443818
[TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis.
Belete MA; Tadesse S; Tilahun M; Gedefie A; Shibabaw A; Mulatie Z; Wudu MA; Gebremichael S; Debash H; Alebachew M; Alemayehu E
Front Immunol; 2024; 15():1362437. PubMed ID: 38524131
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis.
Wang Y; Pei F; Wang X; Sun Z; Hu C; Dou H
Int J Clin Exp Pathol; 2015; 8(10):12319-32. PubMed ID: 26722419
[TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
Krishnamoorthy A; Chandrapalan S; Ahmed M; Arasaradnam RP
J Crohns Colitis; 2024 Feb; 18(2):320-330. PubMed ID: 37540200
[TBL] [Abstract][Full Text] [Related]
5. Fecal calprotectin in assessing inflammatory bowel disease endoscopic activity: a diagnostic accuracy meta-analysis.
Rokkas T; Portincasa P; Koutroubakis IE
J Gastrointestin Liver Dis; 2018 Sep; 27(3):299-306. PubMed ID: 30240474
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis.
Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR
BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994
[TBL] [Abstract][Full Text] [Related]
7. Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.
Dai C; Jiang M; Sun MJ; Cao Q
J Clin Gastroenterol; 2020 Jul; 54(6):545-553. PubMed ID: 30994521
[TBL] [Abstract][Full Text] [Related]
8. Deep Dive Into MicroRNAs in Inflammatory Bowel Disease.
Alfaifi J; Germain A; Heba AC; Arnone D; Gailly L; Ndiaye NC; Viennois E; Caron B; Peyrin-Biroulet L; Dreumont N
Inflamm Bowel Dis; 2023 Jun; 29(6):986-999. PubMed ID: 36545755
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer.
Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337
[TBL] [Abstract][Full Text] [Related]
10. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease.
Yarani R; Shojaeian A; Palasca O; Doncheva NT; Jensen LJ; Gorodkin J; Pociot F
Front Immunol; 2022; 13():865777. PubMed ID: 35734163
[TBL] [Abstract][Full Text] [Related]
11. microRNA in inflammatory bowel disease at a glance.
Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A
Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695
[TBL] [Abstract][Full Text] [Related]
12. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers.
Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC
World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis.
Wu B; Zhen K; Guo L; Sun C
Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186
[No Abstract] [Full Text] [Related]
14. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis.
Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT
Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533
[TBL] [Abstract][Full Text] [Related]
15. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease.
Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS
J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705
[TBL] [Abstract][Full Text] [Related]
16. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test.
Li ZZ; Shen LF; Li YY; Chen P; Chen LZ
Oncotarget; 2016 Sep; 7(36):58569-58578. PubMed ID: 27448977
[TBL] [Abstract][Full Text] [Related]
17. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity.
Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP
Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693
[TBL] [Abstract][Full Text] [Related]
18. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease.
Shaker OG; Safa A; Khairy A; Abozeid NF
Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect?
de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY
World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020
[TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis.
Chen L; Cui Z; Liu Y; Bai Y; Lan F
Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
